Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell

HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell

US Patent 12448413 · Granted Oct 21, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-GPC3 antibody2024
Universal anti-tag chimeric antigen receptor-expressing t cells and methods of t2024
Immunocompetent cell and expression vector expressing regulatory factors of immu2024
Medicine for treating cancer by administering a toll-like receptor agonist and L2023
Medicine for treating cancer by administering a toll-like receptor agonist and L2023
Anti-GPC3 antibody2023
Method for assisting prediction of risk of occurrence of side effect of irinotec2023
Method for assisting prediction of risk of occurrence of side effect of irinotec2023
Enhancer for T-cells or B-cells having memory function, malignant tumor recurren2023
MUC1-derived peptide, and pharmaceutical composition for treatment or prevention2023
MUC1-derived peptide, and pharmaceutical composition for treatment or prevention2023
MUC1-derived peptide, and pharmaceutical composition for treatment or prevention2023